| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6185781 | Gynecologic Oncology | 2013 | 4 Pages |
Abstract
In this series of recurrent platinum-sensitive ovarian cancer patients it could not be confirmed whether beta blocker treatment was associated with better or worse outcome.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Florian Heitz, Andreas du Bois, Philipp Harter, Dirk Lubbe, Christian Kurzeder, Ignace Vergote, Marie Plante, Jacobus Pfisterer, on behalf of the AGO, NCIC-CTG and EORTC-GCG study groups on behalf of the AGO, NCIC-CTG and EORTC-GCG study groups,